| Literature DB >> 35216277 |
Alessio Massironi1,2,3, Albina Ribeiro Franco2,3, Pedro Sousa Babo2,3, Dario Puppi1, Federica Chiellini1, Rui L Reis2,3, Manuela Estima Gomes2,3.
Abstract
Recurrent microbial infections are a major cause of surgical failure and morbidity. Wound healing strategies based on hydrogels have been proposed to provide at once a barrier against pathogen microbial colonization, as well as a favorable environment for tissue repair. Nevertheless, most biocompatible hydrogel materials are more bacteriostatic than antimicrobial materials, and lack specific action against pathogens. Silver-loaded polymeric nanocomposites have efficient and selective activity against pathogenic organisms exploitable for wound healing. However, the loading of metallic nanostructures into hydrogels represents a major challenge due to the low stability of metal colloids in aqueous environments. In this context, the aim of the present study was the development of highly stable silver nanoparticles (AgNPs) as novel potential antimicrobial agents for hyaluronic acids hydrogels. Two candidate stabilizing agents obtained from natural and renewable sources, namely cellulose nanocrystals and ulvan polysaccharide, were exploited to ensure high stability of the silver colloid. Both stabilizing agents possess inherent bioactivity and biocompatibility, as well as the ability to stabilize metal nanostructures thanks to their supramolecular structures. Silver nitrate reduction through sodium borohydride in presence of the selected stabilizing agents was adopted as a model strategy to achieve AgNPs with narrow size distribution. Optimized AgNPs stabilized with the two investigated polysaccharides demonstrated high stability in phosphate buffer saline solution and strong antimicrobial activity. Loading of the developed AgNPs into photocrosslinked methacrylated hyaluronic acid hydrogels was also investigated for the first time as an effective strategy to develop novel antimicrobial wound dressing materials.Entities:
Keywords: cellulose nanocrystals; hydrogels; nanotechnology; polysaccharides; silver nanoparticles; ulvan; wound healing
Mesh:
Substances:
Year: 2022 PMID: 35216277 PMCID: PMC8877827 DOI: 10.3390/ijms23042161
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1UV-vis spectra comparison between selected AgNPs stabilized by CNC and ulvan polysaccharide.
Particle size distribution of selected formulations recorded by DLS and relevant δ-potential values.
| Sample | Diameter (nm) | Size Distribution Graph | Zeta Potential (mV) |
|---|---|---|---|
| CNC0.2 | 188.8 ± 18.5 |
| −37.2 ± 2.8 |
| Ulvan1 | 70.8 ± 11.2 |
| −37.0 ± 0.6 |
Figure 2XRD pattern of CNC0.2_AgNPs and Ulvan1_AgNPs.
Figure 3STEM images of CNC0.2_AgNPs (a,c) and Ulvan1_AgNPs (b,d). (a) CNC0.2_AgNPs; (b) Ulvan1_AgNPs; (c) CNC0.2_AgNPs; (d) Ulvan1_AgNPs.
Figure 4AFM images of CNC0.2_AgNPs (a,c) and Ulvan1_AgNPs (b,d). (a) CNC0.2_AgNPs; (b) Ulvan1_AgNPs; (c) CNC0.2_AgNPs; (d) Ulvan1_AgNPs.
Figure 5(a) FT-IR spectra of CNC0.2_AgNPs and pristine CNC. (b) FT-IR spectra of Ulvan1_AgNPs and pristine Ulvan.
Figure 6(a) UV-vis spectra at different time points of Ulvan1_AgNPs after suspension in PBS 1X. (b) UV-vis spectra at different time points of CNC0.2_AgNPs after suspension in PBS 1X. (a) Ulvan1_AgNPs; (b) CNC0.2_AgNPs.
Figure 7Antibacterial activity of Ulvan1_AgNPs and CNC0.2_AgNPs against Escherichia coli ATCC 25,922, Pseudomonas aeruginosa ATCC 9027 and Staphylococcus aureus ATCC 25,923 after 24 h of incubation in PBS supplemented with 1% TSB and increasing concentration of each AgNPs species (from 0.0065 to 6.5 mg/mL). Data are reported as mean ± standard deviation of at least three independent experiments. Cont: bacteria growth in 1% TSB.
Figure 8FT-IR spectra of methacrylated HA (Met-HA, orange), and native HA (black).
Macroscopical aspect of the obtained hydrogels at the correspondent Ag weight percentage.
| Ag (wt%) | Met-HA-CNC0.2_AgNPs | Met-HA-Ulvan1_AgNPs |
|---|---|---|
| Unloaded |
|
|
| 0.00015 |
|
|
| 0.0015 |
|
|
| 0.00535 |
|
|
| 0.0107 |
|
|
Figure 9Cross-sectional SEM micrographs of hydrogels incorporating (a) CNC0.2_AgNPs and (b) Ulvan1_AgNPs. (a) Met-HA-CNC0.2_AgNPs; (b) Met-HA-Ulvan1_AgNPs; (c) Met-HA-Unload.
Figure 10Schematic representation of the developed hydrogels systems. Candidate groups involved in AgNPs interactions have been underlined in red.
Peak maxima recorded in the UV spectra of synthesized AgNPs formulations.
| Stabilizing Agent | Tested Concentration (mg/mL) | λ Max of Absorption Time 0 (nm) |
|---|---|---|
| Cellulose | 0.2 | unstable |
| 0.20 | 399 | |
| 0.25 | 398 | |
| 0.50 | 397 | |
| 1 | 401 | |
| Ulvan | 0.25 | 392 |
| 0.50 | 396 | |
| 1 | 400 |
Summary of conditions used for the development of Met-HA hydrogels.
| Formulation | Initial Solution | AgNPs Suspension |
|---|---|---|
| Unloaded-Met-HA | HA metacrylate (1.5% | / |
| Met-HA-CNC_AgNPs | HA metacrylate (1.5% | (Ag: 0.0107% |
| Met-HA-Ulvan_AgNPs | HA metacrylate (1.5% | (Ag: 0.0107% |